Intrarectal administration of a GATA3 specific DNAzyme (hgd40) significantly ameliorated colitis in oxazolone and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-mediated colitis models (Popp et al., 2016). This evidence concerns the gene GATA3 and colitis.